Ketamine-induced Deficit of Auditory Gating in the Hippocampus of Rats is Alleviated by Medial Septal Inactivation and Antipsychotic Drugs
Overview
Authors
Affiliations
Rationale: Gating of sensory responses is impaired in schizophrenic patients and animal models of schizophrenia. Ketamine, an N-methyl-D-aspartate receptor antagonist, is known to induce schizophrenic-like symptoms including sensory gating deficits in humans.
Objective: This study aims to investigate the mechanisms underlying ketamine's effect on gating of auditory evoked potentials in the hippocampus of freely moving rats.
Methods: Gating was measured by the ratio of the test-click response (T) to the conditioning-click response (C), or T/C, with T and C measured as peak amplitudes.
Results: Ketamine (1, 3, or 6 mg/kg s.c.) injection dose-dependently increased T/C ratio as compared to saline injection (s.c.). T/C ratio was 0.48 +/- 0.05 after saline injection and 0.73 +/- 0.17 after ketamine (3 mg/kg s.c.) injection. The increase in T/C ratio after ketamine was blocked by prior inactivation of the medial septum with GABA(A) receptor agonist muscimol or by systemic administration of antipsychotic drugs, including chlorpromazine (5 mg/kg i.p.), haloperidol (1 mg/kg i.p.), or clozapine (7.5 mg/kg i.p.). Infusion of muscimol into the medial septum or injection of an antipsychotic drug alone did not affect the T/C ratio. However, rats with selective lesion of the septohippocampal cholinergic neurons by 192 IgG-saporin showed a significantly higher T/C ratio (0.86 +/- 0.10) than sham lesion rats (0.26 +/- 0.07), and ketamine did not further increase T/C ratio in rats with septohippocampal cholinergic neuron lesion.
Conclusions: Ketamine's disruption of hippocampal auditory gating was normalized by inactivation of the medial septum; in addition, septal cholinergic neurons participate in normal auditory gating.
The Consciousness of Pain: A Thalamocortical Perspective.
Sgourdou P NeuroSci. 2024; 3(2):311-320.
PMID: 39483367 PMC: 11523681. DOI: 10.3390/neurosci3020022.
Leung L, Ma J Front Neural Circuits. 2022; 16:895000.
PMID: 35874429 PMC: 9301478. DOI: 10.3389/fncir.2022.895000.
The Medial Septum as a Potential Target for Treating Brain Disorders Associated With Oscillopathies.
Takeuchi Y, Nagy A, Barcsai L, Li Q, Ohsawa M, Mizuseki K Front Neural Circuits. 2021; 15:701080.
PMID: 34305537 PMC: 8297467. DOI: 10.3389/fncir.2021.701080.
Ma J, Leung L Psychopharmacology (Berl). 2017; 234(20):3129-3142.
PMID: 28756462 DOI: 10.1007/s00213-017-4705-7.
Ma J, Leung L Brain Stimul. 2016; 9(5):762-769.
PMID: 27267861 PMC: 4980124. DOI: 10.1016/j.brs.2016.05.006.